Form 4: Nuo Therapeutics CSO/COO Peter Clausen Acquires 15,000 Shares at $0.75

Peter Clausen, CSO/COO of Nuo Therapeutics, purchased 15,000 shares of common stock at $0.75 per share on May 20, 2024, as reported in a Form 4 filing.

Summary

• On May 20, 2024, Peter Clausen, the CSO/COO of Nuo Therapeutics, acquired 15,000 shares of the company's common stock.
• The purchase price was $0.75 per share.
• Following the transaction, Clausen directly owns 586,201 shares of Nuo Therapeutics.
• Clausen also indirectly owns 3,474 shares through his spouse.
• The transaction was approved by the Board of Directors of the Issuer and Non-Employee Directors.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard insider transaction disclosure. The purchase itself is a slightly positive signal, but the document is primarily informational.

Positives

• The CSO/COO's purchase of shares may signal confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.

Stakeholder Impact

• The transaction provides shareholders with insight into the actions of a key company executive.

Key Dates